# Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients

> **NCT00961207** · PHASE4 · TERMINATED · sponsor: **Cook County Health** · enrollment: 2 (actual)

## Conditions studied

- Microalbuminuria
- Macroalbuminuric Diabetic Nephropathy
- Diabetes
- Proteinuria
- Albuminuria

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Aliskiren

## Key facts

- **NCT ID:** NCT00961207
- **Lead sponsor:** Cook County Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2012-07
- **Final completion:** 2012-09
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Altitude trial which used similar drugs was terminated due to increased ADR.
- **Last updated:** 2013-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961207, "Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00961207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*